Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | PKM | P14618 | 2/20 | 0.62 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.62 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.61 |
| ▸ | ALB | P02768 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | PLG | P00747 | 1/20 | 0.58 |
| ▸ | PLAU | P00749 | 1/20 | 0.58 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.58 |
| ▸ | SERPINE1 | P05121 | 4/20 | 0.57 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6359401 | 0.93 | ALB (0.63) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6348677 | 0.92 | SERPINE1 (0.66) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6349987 | 0.92 | ALB (0.57) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6346687 | 0.90 | ALB (0.60) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6359203 | 0.90 | KMT2A (0.58) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6351469 | 0.89 | AKR1C2 (0.66) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6350083 | 0.88 | SERPINE1 (0.68) | KMT2AMEN1MAPTALBF2 | |
| SCHEMBL6348543 | 0.87 | ALB (0.58) | KMT2AMEN1MAPTTDP1PKM | |
| SCHEMBL6349507 | 0.87 | MEN1 (0.57) | KMT2AMEN1PKMSERPINE1GFER | |
| SCHEMBL6353195 | 0.87 | KMT2A (0.52) | KMT2AMEN1MAPTTDP1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
| WO-2004018414-A2 | ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | KMT2A 3645/4885MEN1 3274/4885MAPT 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.